CTA-Sticky-button.png clinicaltrialsyearbook+button

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

oncologytrialsEurope2018-heade.jpg

Protecting product pipeline and rising above competition through optimisation of operationally efficient, specifically targeted oncology clinical trials

Thank you to all our attendees at the Annual Clinical Operations in Oncology Trials Europe Event for making the 2017 meeting such a success! Arena International are delighted to announce CTO Europe will be returning to Munich in November 2018 for another superb year.

The 2017 programme boasted speakers from the likes of Takeda Oncology, Bayer Healthcare, Roche, Medigene and Apeiron Biologics.

Highlight sessions from this year’s event include a lively panel discussion debating the advantages of working with Patient Advocacy Groups; an in-depth case study exploring the considerations when conducting a global oncology trial; and a regulatory insight session identifying how biotechs can achieve EMA approval.

CTO Europe will be returning on 14th & 15th November 2018. Please get in touch if you would be interested in taking part!

event+news+heading+long

Event News

4 Reasons to Attend CTO Europe 2018

Find out why this conference is an unmissable oncology event in Europe

Who should attend this event?

The Clinical Operations in Oncology Trials Europe event offers attendees the unique opportunity to debate and develop practical strategies that will enable their company, whether big or small, to improve their operational efficiency when conducting oncology clinical trials.

A CRO collaboration for oncology trials

Finding the right CRO for your oncology trial can be challenging, as CRO must have expertise specifically in cancer research. However, good collaboration with CRO can contribute to the success of your oncology trial. Smaller companies should also look into outsourcing as a realistic approach and ideally search for a CRO with Risk Based Monitoring (RBM) experience.

Patient recruitment: 4 challenges when it comes to oncology trials

Patient recruitment is challenging when it comes to clinical operations; but it’s even more troubling in oncology specific trials. This article will look at 4 obstacles that are common for patient recruitment and retention in oncology.

Countdown to Clinical Operations in Oncology Trials Europe 2018

ctoeurope_rotating_images.gif



300x250-Subscribe-for-updates-banner+version+2.jpg